MarginsXMarginsX
Home › Markets › Health Care › SOLV

Solventum Corporation (SOLV)

SOLV trades on NYSE in Health Care, Medical/Dental Instruments. Numbers below come from the Nasdaq screener and SEC filings, each with its source.

Price · November 16, 2026
$88.65
-0.48% on the day
Market cap
$15.0B
Large cap
Revenue · 2025
$8.3B
+0.9% on 2024
Net income · 2025
$1.6B
18.7% net margin

Price, change, market cap, sector and industry: Nasdaq stock screener, as of November 16, 2026. Revenue: SEC 10-K (us-gaap:Revenues), fiscal year ended 2025-12-31, https://www.sec.gov/Archives/edgar/data/1964738/000196473826000007/0001964738-26-000007-index.htm. Net income: SEC 10-K (us-gaap:NetIncomeLoss), fiscal year ended 2025-12-31.

Profile

FieldValue
TickerSOLV on NYSE
SectorHealth Care
IndustryMedical/Dental Instruments
CountryUnited States
IPO year2024
SEC CIK0001964738
SEC industry codeSurgical & Medical Instruments & Apparatus
Incorporated inDE

Financials · 2025

LineValue
Revenue$8.3B
Net income$1.6B
Operating income$2.2B
Net margin18.7%
Operating margin26.2%
Revenue growth+0.9%
Cash$878.0M
Total assets$14.3B
P/E (computed)9.7×
P/S (computed)1.8×

Warning signs

Cash runway
Cash-flow positive
$451.0M cash at September 30, 2026
Share count, 1 year
-2.1%
2025-10-31 to 2026-10-31
Going-concern doubt
No
10-Q filed November 5, 2026
Insider net buying, 12 months
$100K
Through September 30, 2026
SignFindingSource
Going concernNo going-concern finding.10-Q 2026-11-05
Cash and burn$451.0M cash; operating cash flow $77.5M a quarter.Report 2026-09-30
Shares outstanding169,739,335 (2026-10-31); 173,447,557 a year earlier.Cover page 2026-10-31
Reverse splits, 3 yearsNone foundNone on EDGAR
Shelf and offerings, 12 months0 S-3/F-3 shelf filings; 0 424B5 takedownsNone on EDGAR
Exchange deficiency notices, 12 monthsNoneNone on EDGAR
AuditorPricewaterhouseCoopers LLP, Minneapolis, Minnesota, United StatesPCAOB Form AP 2026-03-18
Late filings, 12 monthsNoneNone on EDGAR
Insider trades, 12 monthsBought $100K, sold $0 on the open marketSEC Forms 3/4/5 data sets 2026-09-30

From SEC EDGAR submissions, EDGAR full-text search, SEC's Forms 3/4/5 data sets and PCAOB Form AP; computed November 16, 2026. Runway is cash divided by average quarterly operating cash burn. Dilution compares cover-page share counts, corrected for recorded splits.

Quarterly results

QuarterRevenueNet incomeOp. cash flowCashTotal debtTTM revenueSource
Q3 2026
2026-09-30
$1.9B-$12.0M$177.0M$451.0M$5.1B$8.2B10-Q 2026-11-05
Q2 2026
2026-06-30
$2.2B$92.0M$227.0M$403.0M$5.1B$8.3B10-Q 2026-08-05
Q1 2026
2026-03-31
$2.0B$13.0M-$189.0M$561.0M$5.1B$8.3B10-Q 2026-05-05
Q4 2025
2025-12-31
$2.0B$63.0M$95.0M$878.0M$5.0B$8.3B10-K 2026-02-27
Q3 2025
2025-09-30
$2.1B$1.3B$76.0M$1.6B$5.1B$8.4B10-Q 2026-11-05
Q2 2025
2025-06-30
$2.2B$90.0M$169.0M$492.0M$7.8B$8.4B10-Q 2026-08-05
Q1 2025
2025-03-31
$2.1B$137.0M$29.0M$534.0M$7.9B$8.3B10-Q 2026-05-05
Q4 2024
2024-12-31
$2.1B$31.0M$219.0M$762.0M$8.0B$8.3B10-K 2026-02-27

From SEC XBRL company facts. Quarters a filing gives only as year-to-date are computed as differences (Q4 is the fiscal year minus nine months).

Key SEC documents

DocumentFormFiled
Latest prospectus or offering document424B72025-08-14
Latest annual report10-K2026-02-27
Latest quarterly / interim10-Q2026-11-05
Latest current report8-K2026-11-05
Latest proxyDEFA14A2026-03-27

Source: SEC EDGAR submissions feed, 263 recent filings. All filings on EDGAR.

Price moves

WindowReturn
1 week-1.4%
1 month+3.2%
3 months+3.0%
Year to date+12.4%
1 year+18.4%
From 52-week high-3.6%

Source: Yahoo Finance daily closes, last bar 2026-11-13. Computed by MarginsX from daily closes; cap, sector and tier from the Nasdaq screener.

Peers in Medical/Dental Instruments

TickerCompanyPriceDayMarket cap
GKOSGlaukos Corporation$244.88-0.34%$14.5B
BAXBaxter International Inc.$25.54-1.05%$13.2B
PENPenumbra Inc.$320.62-0.09%$12.6B
PODDInsulet Corporation$145.29-4.72%$10.1B
GMEDGlobus Medical Inc.$70.50-2.27%$9.3B
WSTWest Pharmaceutical Services Inc.$417.80+0.33%$29.1B
DXCMDexCom Inc.$81.61-2.06%$30.4B
RMDResMed Inc.$238.19-0.56%$33.5B

The full dossier has every filing, three years of financials, private raises and the people who signed them.

Open the full dossier